Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice

Lawrence, 2002, Anti-inflammatory lipid mediators and insights into the resolution of inflammation, Nat Rev Immunol, 2, 787, 10.1038/nri915

Liu, 2006, NF-κB activation as a pathological mechanism of septic shock and inflammation, Am J Physiol Lung Cell Mol Physiol, 290, L622, 10.1152/ajplung.00477.2005

Barnes, 1997, Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases, N Engl J Med, 336, 1066, 10.1056/NEJM199704103361506

Ricciotti, 2011, Prostaglandins and inflammation, Arterioscler Thromb Vasc Biol, 31, 986, 10.1161/ATVBAHA.110.207449

Poligone, 2001, Positive and negative regulation of NF-κB by COX-2, J Biol Chem, 276, 38658, 10.1074/jbc.M106599200

Katagiri, 2008, TNF-alpha induces thromboxane receptor signaling-dependent microcirculatory dysfunction in mouse liver, Shock, 30, 463, 10.1097/SHK.0b013e3181673f54

Deng, 2010, Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation, J Mol Cell Cardiol, 48, 331, 10.1016/j.yjmcc.2009.10.022

Deng, 2011, Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice, FASEB J, 25, 703, 10.1096/fj.10-171488

Jung, 2010, Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease, PLoS ONE, 5, e11979, 10.1371/journal.pone.0011979

Schmelzer, 2006, Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors, Proc Natl Acad Sci USA, 103, 13646, 10.1073/pnas.0605908103

Kerfoot, 2005, Local coordination verses systemic disregulation: complexities in leukocyte recruitment revealed by local and systemic activation of TLR4 in vivo, J Leukoc Biol, 77, 862, 10.1189/jlb.1004607

Lee, 2010, Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice, FASEB J, 24, 3770, 10.1096/fj.10-160119

Sinal, 2000, Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation, J Biol Chem, 275, 40504, 10.1074/jbc.M008106200

Seubert, 2006, Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function, Circ Res, 99, 442, 10.1161/01.RES.0000237390.92932.37

Panigrahy, 2012, Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice, J Clin Invest, 122, 178, 10.1172/JCI58128

Edin, 2011, Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia–reperfusion injury in isolated mouse heart, FASEB J, 25, 3436, 10.1096/fj.11-188300

Kim, 2001, Indomethacin-loaded methoxy poly(ethylene glycol)/poly(ɛ-caprolactone) diblock copolymeric nanosphere: Pharmacokinetic characteristics of indomethacin in the normal Sprague–Dawley rats, Biomaterials, 22, 2049, 10.1016/S0142-9612(00)00393-8

Fitzpatrick, 1986, Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry, J Biol Chem, 261, 15334, 10.1016/S0021-9258(18)66872-3

Kozak, 2003, 11,12-Epoxyeicosatrienoic acid attenuates synthesis of prostaglandin E2 in rat monocytes stimulated with lipopolysaccharide, Exp Biol Med, 228, 786, 10.1177/15353702-0322807-03

Inceoglu, 2008, Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways, Proc Natl Acad Sci USA, 105, 18901, 10.1073/pnas.0809765105

Schmelzer, 2005, Soluble epoxide hydrolase is a therapeutic target for acute inflammation, Proc Natl Acad Sci USA, 102, 9772, 10.1073/pnas.0503279102

Michaelis, 2005, Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce the expression of cyclooxygenase-2 in endothelial cells, Arterioscler Thromb Vasc Biol, 25, 321, 10.1161/01.ATV.0000151648.58516.eb

Calvert, 2008, Deficiency of mitogen-activated protein kinase phosphatase-1 results in iNOS-mediated hypotension in response to low-dose endotoxin, Am J Physiol Heart Circ Physiol, 294, H1621, 10.1152/ajpheart.01008.2007

Inceoglu, 2011, Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP, Proc Natl Acad Sci USA, 108, 5093, 10.1073/pnas.1101073108

Copeland, 2005, Acute inflammatory response to endotoxin in mice and humans, Clin Diagn Lab Immunol, 12, 60, 10.1128/CDLI.12.1.60-67.2005

Rojas, 2005, Endotoxin-induced lung injury in mice: structural, functional, and biochemical responses, Am J Physiol Lung Cell Mol Physiol, 288, L333, 10.1152/ajplung.00334.2004

Behm, 2009, Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: Identification of a novel mechanism of vasodilation, J Pharmacol Exp Ther, 328, 231, 10.1124/jpet.108.145102

Senouvo, 2011, Improved bioavailability of epoxyeicosatrienoic acids reduces TP-receptor agonist-induced tension in human bronchi, Am J Physiol Lung Cell Mol Physiol, 301, L675, 10.1152/ajplung.00427.2010

Zuccollo, 2005, The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus, Circulation, 112, 3001, 10.1161/CIRCULATIONAHA.105.581892